108 related articles for article (PubMed ID: 27357208)
1. A recombinant plasmid containing CpG motifs as a novel vaccine adjuvant for immune protection against herpes simplex virus 2.
He Z; Xu J; Tao W; Fu T; He F; Hu R; Jia L; Hong Y
Mol Med Rep; 2016 Aug; 14(2):1823-8. PubMed ID: 27357208
[TBL] [Abstract][Full Text] [Related]
2. Co-immunization with plasmids coding the full length and a soluble form of glycoprotein D of HSV-2 induces protective cellular and humoral immune response in mice.
Fló J
Vaccine; 2003 Mar; 21(11-12):1239-45. PubMed ID: 12559804
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of DNA vaccine potency against herpes simplex virus 1 by co-administration of an interleukin-18 expression plasmid as a genetic adjuvant.
Zhu M; Xu X; Liu H; Liu X; Wang S; Dong F; Yang B; Song G
J Med Microbiol; 2003 Mar; 52(Pt 3):223-228. PubMed ID: 12621087
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules.
Fló J; Tisminetzky S; Baralle F
Immunology; 2000 Jun; 100(2):259-67. PubMed ID: 10886404
[TBL] [Abstract][Full Text] [Related]
5. Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
Meseda CA; Elkins KL; Merchlinsky MJ; Weir JP
J Infect Dis; 2002 Oct; 186(8):1065-73. PubMed ID: 12355355
[TBL] [Abstract][Full Text] [Related]
6. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.
Sin JI; Kim JJ; Arnold RL; Shroff KE; McCallus D; Pachuk C; McElhiney SP; Wolf MW; Pompa-de Bruin SJ; Higgins TJ; Ciccarelli RB; Weiner DB
J Immunol; 1999 Mar; 162(5):2912-21. PubMed ID: 10072541
[TBL] [Abstract][Full Text] [Related]
7. Anti-glycoprotein g antibodies of herpes simplex virus 2 contribute to complete protection after vaccination in mice and induce antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
Görander S; Ekblad M; Bergström T; Liljeqvist JÅ
Viruses; 2014 Nov; 6(11):4358-72. PubMed ID: 25398047
[TBL] [Abstract][Full Text] [Related]
8. [Enhancement of herpes simplex virus-1 glycoprotein-D DNA vaccine induced specific immune responses by coimmunization with interleukin-2 genetic adjuvant].
Liu XJ; Zhu MZ; Song GX; Xu YF; Liu HW; Wang S; Yang BL; Dong FT; Xu XM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):67-72. PubMed ID: 15782496
[TBL] [Abstract][Full Text] [Related]
9. DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome.
Meseda CA; Schmeisser F; Pedersen R; Woerner A; Weir JP
Virology; 2004 Jan; 318(1):420-8. PubMed ID: 14972567
[TBL] [Abstract][Full Text] [Related]
10. A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in mice.
Dutton JL; Li B; Woo WP; Marshak JO; Xu Y; Huang ML; Dong L; Frazer IH; Koelle DM
PLoS One; 2013; 8(10):e76407. PubMed ID: 24098493
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
Sin JI; Kim JJ; Zhang D; Weiner DB
Hum Gene Ther; 2001 Jun; 12(9):1091-102. PubMed ID: 11399230
[TBL] [Abstract][Full Text] [Related]
12. Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide.
Mahmood MS; Siddique M; Hussain I; Khan A; Mansoor MK
Vaccine; 2006 May; 24(22):4838-46. PubMed ID: 16600440
[TBL] [Abstract][Full Text] [Related]
13. CpG/Poly (I:C) mixed adjuvant priming enhances the immunogenicity of a DNA vaccine against eastern equine encephalitis virus in mice.
Ma J; Wang H; Zheng X; Xue X; Wang B; Wu H; Zhang K; Fan S; Wang T; Li N; Zhao Y; Gao Y; Yang S; Xia X
Int Immunopharmacol; 2014 Mar; 19(1):74-80. PubMed ID: 24440303
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection.
Önnheim K; Ekblad M; Görander S; Bergström T; Liljeqvist JÅ
Viruses; 2016 Apr; 8(4):110. PubMed ID: 27110813
[TBL] [Abstract][Full Text] [Related]
15. Protective immune correlates can segregate by vaccine type in a murine herpes model system.
Sin JI; Ayyavoo V; Boyer J; Kim J; Ciccarelli RB; Weiner DB
Int Immunol; 1999 Nov; 11(11):1763-73. PubMed ID: 10545480
[TBL] [Abstract][Full Text] [Related]
16. Multi-antigenic DNA immunization using herpes simplex virus type 2 genomic fragments.
Braun RP; Dong L; Jerome S; Herber R; Roberts LK; Payne LG
Hum Vaccin; 2008; 4(1):36-43. PubMed ID: 18438102
[TBL] [Abstract][Full Text] [Related]
17. Macrophage inflammatory protein-1alpha expression plasmid enhances DNA vaccine-induced immune responses against HSV-2.
Shao W; Li X; Li M; Shi L; Qin Y; Li K
Immunol Cell Biol; 2005 Dec; 83(6):626-31. PubMed ID: 16266314
[TBL] [Abstract][Full Text] [Related]
18. Plasmid containing CpG oligodeoxynucleotides can augment the immune responses of pigs immunized with porcine reproductive and respiratory syndrome killed virus vaccine.
Quan Z; Qin ZG; Zhen W; Feng XZ; Hong J; Fei ZH
Vet Immunol Immunopathol; 2010 Aug; 136(3-4):257-64. PubMed ID: 20394988
[TBL] [Abstract][Full Text] [Related]
19. Improvement of the Immunogenicity of Porcine Circovirus Type 2 DNA Vaccine by Recombinant ORF2 Gene and CpG Motifs.
Li J; Shi JL; Wu XY; Fu F; Yu J; Yuan XY; Peng Z; Cong XY; Xu SJ; Sun WB; Cheng KH; Du YJ; Wu JQ; Wang JB; Huang BH
Viral Immunol; 2015 Jun; 28(5):290-6. PubMed ID: 26046831
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of recombinant herpes simplex virus 1 glycoprotein D candidate vaccines in mice.
Durmanová V; Mosko T; Sapák M; Kosovský J; Rezuchová I; Buc M; Rajcáni J
Acta Microbiol Immunol Hung; 2006 Dec; 53(4):459-77. PubMed ID: 17278713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
